Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

4.57
 
USD
  
-0.02
  
(-0.44%)
Optionable: Yes  Market Cap: 183 M  90-day average vol: 714,351

Previous close: 4.59  Open: 4.64  Bid: 4.51  Ask: 4.65
52 week range    
2.83   
   9.01
Last updated: Monday 17th June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

ABEO Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends3 M3 M4 M
AcquiredInProcessRnD8 M
AcquiredInProcessRnDIncome-23 M
Amortization of intangibles-9000.0-538000.0-677000.0-534000.0-1 M-5 M32 M117000.0
Basic EPS from continuing operations-22.75-21.5-5.53
Basic EPS total1.5-381.5-22.75-21.5-5.53
Basic weighted shares outstanding1 M77716.01 M1 M2 M2 M2 M4 M4 M8 M
Cost of sales-125000.0
Depreciation3000.011000.0551000.0825000.0741000.02 M8 M5 M3 M3 M
Depreciation unreconciled3000.011000.0551000.0825000.0741000.02 M8 M5 M3 M
DepreciationAndAmortization3000.011000.0551000.0825000.0741000.02 M8 M5 M3 M3 M
Diluted EPS total1.5-381.5-13.25-16.0-16.5-29.75-37.75-22.75-21.5-5.53
Diluted normalized net income/share-37.75
Diluted weighted shares outstanding1 M77716.01 M1 M2 M2 M2 M4 M4 M8 M
GainOnSaleOfPPE292000.0
GainOnSaleOfSecurity9 M45000.04 M2 M525000.02 M
GeneralAndAdministrativeExpense-270000.04 M14 M13 M11 M20 M21 M24 M22 M17 M
Gross operating profit2 M925000.01 M889000.0837000.03 M10 M3 M1 M
ImpairmentOfCapitalAssets33 M2 M
Income before tax4 M-27 M-15 M-22 M-27 M-58 M-77 M-86 M-93 M-31 M
Income taxes-8 M-14000.0-34 M-8 M
Interest income-6000.0-6000.0-8000.04 M
InterestExpenseNonOperating11000.0400000.04 M4 M736000.0
InterestExpenseOperating-7000.0
InterestIncomeOperating40000.0431000.0
MiscOtherSpecialCharges251000.045000.04 M2 M525000.012 M
Net income from total operations4 M-27 M-15 M-22 M-27 M-57 M-76 M-84 M-85 M-40 M
NetIncomeCommonStockholders2 M-30 M-15 M-22 M-27 M-57 M-76 M-84 M-85 M-43 M
NetIncomeContinuousOperations4 M-27 M-15 M-22 M-27 M-57 M-76 M-84 M-85 M-40 M
NetIncomeFromOtherGainsLosses-8000.02 M1 M1 M8 M
NetNonOperatingInterestIncomeExpense-279000.0-582000.0-6000.0-6000.0-8000.0-11000.0-400000.0-4 M-4 M-736000.0
Operating income-4 M-3 M-19 M-24 M-28 M-58 M-77 M-81 M-90 M-51 M
Operating income before depreciation (EBITDA)4 M-27 M-14 M-21 M-27 M-56 M-69 M-76 M-85 M-26 M
OperatingExpense6 M4 M20 M25 M-29 M-61 M77 M91 M93 M52 M
Other income net-9 M23 M-4 M-2 M-525000.0-2 M-9000.0-10 M
Other special charges-15000.0-141000.0
OtherGandA-270000.04 M14 M13 M11 M20 M21 M24 M22 M17 M
OtherImpairmentOfCapitalAssets1 M
OtherOperatingExpenses-2 M33 M2 M-4 M
OtherunderPreferredStockDividend3 M3 M4 M
PreferredStockDividends3 M3 M4 M
RentAndLandingFees-270000.04 M14 M13 M11 M20 M
Research & development expense884000.0333000.05 M11 M17 M39 M49 M30 M39 M29 M
ResearchExpense884000.0333000.05 M11 M17 M39 M49 M30 M39 M29 M
Revenue per share-9000.0-538000.0-677000.0-534000.0-1 M-5 M32 M117000.0
SalariesAndWages-439000.0-1 M-4 M-5 M-5 M-8 M-7 M6 M5 M
Selling Gen & administrative expense5 M4 M14 M13 M11 M20 M21 M24 M22 M17 M
SellingAndMarketingExpense5 M4 M
SellingExpense5 M4 M
Special income/charges8 M-32 M-2 M
Total Income available for interest expense (EBIT)4 M-27 M-15 M-22 M-27 M-58 M-77 M-81 M-90 M-30 M
Total common shares outstanding21619.0799552.01 M2 M2 M2 M3 M4 M6 M18 M
Total net income4 M-27 M-15 M-22 M-27 M-57 M-76 M-84 M-85 M-40 M
Total ordinary shares41 M41 M41 M41 M41 M41 M41 M41 M41 M41 M
Total revenues2 M925000.01 M889000.0837000.03 M10 M3 M1 M
TotalExpenses6 M4 M20 M25 M-29 M-61 M77 M91 M93 M52 M
TotalRevenue2 M925000.01 M889000.0837000.03 M10 M3 M1 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University